{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:41:52Z","timestamp":1790203312531,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI22C1609"],"award-info":[{"award-number":["HI22C1609"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2022-NR070174"],"award-info":[{"award-number":["RS-2022-NR070174"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118686","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:38:31Z","timestamp":1761323911000},"page":"118686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Serdemetan promotes bone regeneration via coordinated regulation of osteoblast and osteoclast activity"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7770-1890","authenticated-orcid":false,"given":"Sol","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Chan","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Ju","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungjoon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Man","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soonchul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118686_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biomaterials.2018.07.017","article-title":"Bone regeneration strategies: engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives","volume":"180","author":"Ho-Shui-Ling","year":"2018","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biopha.2025.118686_bib2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s40001-021-00593-9","article-title":"Strategies for large bone defect reconstruction after trauma, infections or tumour excision: a comprehensive review of the literature","volume":"26","author":"Migliorini","year":"2021","journal-title":"Eur. J. Med. Res."},{"issue":"14","key":"10.1016\/j.biopha.2025.118686_bib3","doi-asserted-by":"crossref","first-page":"8471","DOI":"10.3390\/app13148471","article-title":"Current options and future perspectives on bone graft and biomaterials substitutes for bone repair, from clinical needs to advanced biomaterials research","volume":"13","author":"Georgeanu","year":"2023","journal-title":"Appl. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118686_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5312\/wjo.v7.i3.171","article-title":"Major osteoporotic fragility fractures: risk factor updates and societal impact","volume":"7","author":"Pisani","year":"2016","journal-title":"World J. Orthop."},{"issue":"11","key":"10.1016\/j.biopha.2025.118686_bib5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3949\/ccjm.85a.17119","article-title":"Bisphosphonate-related atypical femoral fracture: managing a rare but serious complication","volume":"85","author":"Silverman","year":"2018","journal-title":"Clevel. Clin. J. Med."},{"issue":"3","key":"10.1016\/j.biopha.2025.118686_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.drudis.2013.07.015","article-title":"Treating osteoporosis by targeting parathyroid hormone to bone","volume":"19","author":"Ponnapakkam","year":"2014","journal-title":"Drug Discov. Today"},{"issue":"12","key":"10.1016\/j.biopha.2025.118686_bib7","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1111\/bcp.15110","article-title":"Long-term bisphosphonate therapy and atypical femoral fracture: can you have too much of a good thing?","volume":"87","author":"Walker","year":"2021","journal-title":"Br. J. Clin. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2025.118686_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11154-010-9153-1","article-title":"Cellular mechanisms of bone remodeling","volume":"11","author":"Eriksen","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"1","key":"10.1016\/j.biopha.2025.118686_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41413-022-00219-8","article-title":"Bone remodeling: an operational process ensuring survival and bone mechanical competence","volume":"10","author":"Bolamperti","year":"2022","journal-title":"Bone Res."},{"key":"10.1016\/j.biopha.2025.118686_bib10","series-title":"Reports of the Surgeon General, Bone Health and Osteoporosis: A Report of the Surgeon General","article-title":"Of the surgeon","author":"Office","year":"2004"},{"issue":"4","key":"10.1016\/j.biopha.2025.118686_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15188","article-title":"P53 negatively regulates the osteogenic differentiation in jaw bone marrow MSCs derived from diabetic osteoporosis","volume":"9","author":"Zheng","year":"2023","journal-title":"Heliyon"},{"issue":"24","key":"10.1016\/j.biopha.2025.118686_bib12","doi-asserted-by":"crossref","first-page":"21843","DOI":"10.1074\/jbc.M109745200","article-title":"Akt enhances Mdm2-mediated ubiquitination and degradation of p53","volume":"277","author":"Ogawara","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2025.118686_bib13","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2003193118","article-title":"Mdm2 phosphorylation by akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis","volume":"118","author":"Chibaya","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118686_bib14","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/stem.1925","article-title":"p53 loss increases the osteogenic differentiation of bone marrow stromal cells","volume":"33","author":"He","year":"2015","journal-title":"STEM CELLS"},{"issue":"1","key":"10.1016\/j.biopha.2025.118686_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41418-020-0590-4","article-title":"Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin","volume":"28","author":"Velletri","year":"2021","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.biopha.2025.118686_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41419-023-05844-7","article-title":"Mdm2\/p53 levels in bone marrow mesenchymal stromal cells are essential for maintaining the hematopoietic niche in response to DNA damage","volume":"14","author":"Pourebrahim","year":"2023","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.biopha.2025.118686_bib17","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1359\/jbmr.070618","article-title":"MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway","volume":"22","author":"Zauli","year":"2007","journal-title":"J. Bone Min. Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118686_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/jmcb\/mjw046","article-title":"Mdm2 as a chromatin modifier","volume":"9","author":"Wienken","year":"2017","journal-title":"J. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118686_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074741","article-title":"Serdemetan antagonizes the Mdm2-HIF1\u03b1 axis leading to decreased levels of glycolytic enzymes","volume":"8","author":"Lehman","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2025.118686_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbamcr.2019.01.012","article-title":"Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts","volume":"1866","author":"Daniele","year":"2019","journal-title":"Biochim Biophys. Acta Mol. Cell Res"},{"key":"10.1016\/j.biopha.2025.118686_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122425","article-title":"Targeting class a GPCRs for hard tissue regeneration","volume":"304","author":"Park","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.118686_bib22","article-title":"Development of MDM2-Targeting PROTAC for advancing bone regeneration","author":"Jeong","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"7","key":"10.1016\/j.biopha.2025.118686_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"38","key":"10.1016\/j.biopha.2025.118686_bib24","doi-asserted-by":"crossref","first-page":"32930","DOI":"10.1074\/jbc.M500154200","article-title":"Regulation of actin ring formation by rho GTPases in osteoclasts","volume":"280","author":"Chellaiah","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"5434","key":"10.1016\/j.biopha.2025.118686_bib25","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1126\/science.285.5434.1733","article-title":"A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy","volume":"285","author":"Komarov","year":"1999","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.biopha.2025.118686_bib26","doi-asserted-by":"crossref","first-page":"13987","DOI":"10.1074\/jbc.M901758200","article-title":"MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation","volume":"284","author":"Fu","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2025.118686_bib27","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bone.2012.05.012","article-title":"IFITM1 increases osteogenesis through Runx2 in human alveolar-derived bone marrow stromal cells","volume":"51","author":"Kim","year":"2012","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.biopha.2025.118686_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3892\/ijo.2017.3834","article-title":"AURKA, DLGAP5, TPX2, KIF11 and CKAP5: five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients","volume":"50","author":"Schneider","year":"2017","journal-title":"Int J. Oncol."},{"issue":"37","key":"10.1016\/j.biopha.2025.118686_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2413089121","article-title":"The mitotic checkpoint complex controls the association of Cdc20 regulatory protein with the ubiquitin ligase APC\/C in mitosis","volume":"121","author":"Sitry-Shevah","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.biopha.2025.118686_bib30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/sj.cdd.4401130","article-title":"Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe","volume":"9","author":"Castedo","year":"2002","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.biopha.2025.118686_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/15384101.2015.1120925","article-title":"Coordinating cell proliferation and differentiation: antagonism between cell cycle regulators and cell type-specific gene expression","volume":"15","author":"Ruijtenberg","year":"2016","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.biopha.2025.118686_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.devcel.2014.03.012","article-title":"Cyclin B1\/Cdk1 coordinates mitochondrial respiration for cell-cycle G2\/M progression","volume":"29","author":"Wang","year":"2014","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2025.118686_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/MCB.06159-11","article-title":"Role of AMPK-mTOR-Ulk1\/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks","volume":"32","author":"Alers","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118686_bib34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biochi.2015.07.024","article-title":"The stress protein TP53INP1 plays a tumor suppressive role by regulating metabolic homeostasis","volume":"118","author":"Saadi","year":"2015","journal-title":"Biochimie"},{"issue":"8","key":"10.1016\/j.biopha.2025.118686_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024478","article-title":"SVIP induces localization of p97\/VCP to the plasma and lysosomal membranes and regulates autophagy","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2025.118686_bib36","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.4161\/cc.8.10.8498","article-title":"Stimulation of autophagy by the p53 target gene Sestrin2","volume":"8","author":"Maiuri","year":"2009","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.biopha.2025.118686_bib37","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/15548627.2017.1421884","article-title":"IL4 (interleukin 4) induces autophagy in b cells leading to exacerbated asthma","volume":"14","author":"Xia","year":"2018","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.biopha.2025.118686_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2006.05.034","article-title":"DRAM, a p53-induced modulator of autophagy, is critical for apoptosis","volume":"126","author":"Crighton","year":"2006","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biopha.2025.118686_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ceb.2009.12.001","article-title":"Autophagy regulation by p53","volume":"22","author":"Maiuri","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118686_bib40","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/cdd.2012.30","article-title":"TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family proteins through the LC3-interacting region (LIR) and promotes autophagy-dependent cell death","volume":"19","author":"Seillier","year":"2012","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.biopha.2025.118686_bib41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jcp.22768","article-title":"Autophagy regulates hypoxia-induced osteoclastogenesis through the HIF-1alpha\/BNIP3 signaling pathway","volume":"227","author":"Zhao","year":"2012","journal-title":"J. Cell Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118686_bib42","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.devcel.2011.08.016","article-title":"Autophagy proteins regulate the secretory component of osteoclastic bone resorption","volume":"21","author":"DeSelm","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.biopha.2025.118686_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.diff.2021.08.003","article-title":"Beclin 1 positively regulates osteoprotegerin-induced inhibition of osteoclastogenesis by increasing autophagy in vitro","volume":"121","author":"Tong","year":"2021","journal-title":"Differentiation"},{"issue":"16","key":"10.1016\/j.biopha.2025.118686_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22169067","article-title":"Paradoxical Pro-angiogenic effect of Low-Dose ellipticine identified by in silico drug repurposing","volume":"22","author":"Oh","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118686_bib45","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.cbpa.2007.08.033","article-title":"Virtual screening strategies in drug discovery","volume":"11","author":"McInnes","year":"2007","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118686_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.canlet.2011.08.011","article-title":"Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts","volume":"312","author":"Chargari","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2025.118686_bib47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.abb.2018.04.004","article-title":"Proteomic investigating the cooperative lethal effect of EGFR and MDM2 inhibitors on ovarian carcinoma","volume":"647","author":"Chang","year":"2018","journal-title":"Arch. Biochem Biophys."},{"issue":"5","key":"10.1016\/j.biopha.2025.118686_bib48","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026070","article-title":"p53 in the DNA-Damage-Repair process","volume":"6","author":"Williams","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med"},{"issue":"7","key":"10.1016\/j.biopha.2025.118686_bib49","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0344-0338(96)80088-4","article-title":"The role of p53 in cell cycle regulation","volume":"192","author":"Shaw","year":"1996","journal-title":"Pathol. Res Pr."},{"issue":"4","key":"10.1016\/j.biopha.2025.118686_bib50","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/ten.teb.2015.0357","article-title":"A review of the clinical side effects of bone morphogenetic Protein-2","volume":"22","author":"James","year":"2016","journal-title":"Tissue Eng. Part B Rev."},{"issue":"2","key":"10.1016\/j.biopha.2025.118686_bib51","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/pbc.23319","article-title":"Initial testing of JNJ-26854165 (Serdemetan) by the pediatric preclinical testing program","volume":"59","author":"Smith","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2025.118686_bib52","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.yexcr.2012.02.022","article-title":"p53 and MDM2 are involved in the regulation of osteocalcin gene expression","volume":"318","author":"Chen","year":"2012","journal-title":"Exp. Cell Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118686_bib53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1083\/jcb.200507106","article-title":"p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling","volume":"172","author":"Wang","year":"2006","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118686_bib54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41413-023-00257-w","article-title":"New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis","volume":"11","author":"Hasco\u00ebt","year":"2023","journal-title":"Bone Res"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:49:00Z","timestamp":1775782140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225008807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":54,"alternative-id":["S0753332225008807"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118686","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serdemetan promotes bone regeneration via coordinated regulation of osteoblast and osteoclast activity","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118686"}}